HomeResearchFunded ProjectsWP 1.3: FRAGINOC study: The impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer

WP 1.3: FRAGINOC study: The impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer

Feb 13, 2024

Epithelial ovarian cancer (EOC) is often diagnosed in older comorbid women. Extensive surgery (primary debulking surgery (PDS) or neoadjuvant chemotherapy (NACT) with interval debulking surgery (IDS)) with no residual disease is the most important prognostic factor. However, 40% of patients ≥70 years are not operated due to extent of disease, frailty, or fear of complications. Frailty screening and a Comprehensive Geriatric Assessment (CGA) are recommended in oncologic geriatrics. However, known frailty screening tools are inaccurate and CGA is time-consuming and expensive. Their impact has never been assessed in EOC patients.

Awarded to: Tine Schnack Henrichsen (SDU) – CFA1

Awarded grant to support TAP personnel.

Tine-Henrichsen-Schnack.jpg